A comprehensive view of Koninklijke Philips (Royal Philips). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.
Koninklijke Philips PHG receives FDA warning letter over manufacturing issues with its Incisive CT patient interface monitor in China; FDA cites violations in control over goods and services and insufficient reporting on device modifications
Published:
April 26, 2024
by Zack's Commentary
|
Koninklijke Philips (Royal Philips) Champions Ethical AI in Healthcare, Showcases Industry-Leading Innovations and Educational Initiatives
Published:
April 20, 2024
by Industry Intelligence Inc.
|
Koninklijke Philips (Royal Philips) Accelerates Healthcare Innovation with AI-Integrated Personal Health Products and Advanced Diagnostic Speeds
Published:
April 02, 2024
by Industry Intelligence Inc.
|
Koninklijke Philips Announces New CMO, Addresses Indian Healthcare's Sustainability Barriers and Advocates for Greener Health Technologies
Published:
March 30, 2024
by Industry Intelligence Inc.
|
Koninklijke Philips (Royal Philips) Leads in Health Tech Innovation with Advanced 14 Tesla MRI and Spectral CT Imaging, Bolsters Inclusivity and Gender Diversity Initiatives
Published:
March 29, 2024
by Industry Intelligence Inc.
|
Ask us about our Government & Public Policy market view